XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity (Deficit):
6 Months Ended
Jun. 30, 2018
Shareholders' Equity (Deficit):  
Shareholders' Equity (Deficit):

8.  Shareholders’ Equity (Deficit):

 

Dividends

 

On January 24, 2018, the Company’s Board of Directors approved the payment of a $0.11 per share quarterly cash dividend to shareholders of record at the close of business on February 7, 2018, which was paid on March 1, 2018.

 

On April 25, 2018, the Company’s Board of Directors approved the payment of a $0.15 per share quarterly cash dividend to shareholders of record at the close of business on May 9, 2018, which was paid on June 1, 2018.

 

Repurchase of Common Stock

 

In the first six months of 2018 the Company repurchased no shares of its common stock.  Under the Board of Directors’ authorization, as of June 30, 2018, the Company has the ability to repurchase an additional 142,988 shares of its common stock.  Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing.

 

Stock Option Plans and Stock-Based Compensation

 

The Company had authorized up to 750,000 shares of common stock be reserved for granting either nonqualified or incentive stock options to officers and key employees under the Company’s 2001 Stock Option Plan (the “2001 Plan”).  The 2001 Plan expired on February 20, 2011. As of June 30, 2018, the Company has authorized up to 700,000 shares of common stock to be reserved for granting either nonqualified or incentive stock options to officers and key employees under the Company’s 2010 Stock Option Plan (the “2010 Plan”).

 

The Company also sponsors a Stock Option Plan for Nonemployee Directors (the “Nonemployee Directors Plan”) and has reserved a total of 350,000 shares for issuance to directors of the Company who are not employees.

 

Stock option activity under the 2001 Plan, 2010 Plan and Nonemployee Directors Plan (collectively, the “Option Plans”) as of June 30, 2018 was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted Average

    

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

Number of

 

Weighted Average

 

Contractual Life

 

 

 

 

 

Shares

 

Exercise Price

 

(years)

 

 

Intrinsic Value

Outstanding, December 30, 2017

 

658,184

 

$

72.33

 

5.87

 

$

37,723,800

Granted

 

35,000

 

 

143.20

 

 

 

 

 

Exercised

 

(27,697)

 

 

41.39

 

 

 

 

 

Forfeited

 

(4,063)

 

 

113.95

 

 

 

 

 

Outstanding, June 30, 2018

 

661,424

 

$

77.12

 

5.69

 

$

47,178,100

Exercisable, June 30, 2018

 

487,335

 

$

62.07

 

4.66

 

$

42,095,400

 

 

The fair value of options granted under the Option Plans during the first six months of 2018 and 2017 were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions and results:

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

    

June 30, 2018

 

July 1, 2017

 

    

Risk free interest rate

 

 

2.73

%

 

1.90

%

 

Expected life (years)

 

 

 6

 

 

 6

 

 

Expected volatility

 

 

20.40

%

 

26.93

%

 

Dividend yield

 

 

1.17

%

 

1.14

%

 

Option fair value

 

$

31.44

 

$

31.38

 

 

 

During the six months ended June 30, 2018, option holders surrendered 2,249 shares of previously owned common shares as payment for options shares exercised as provided for by the Option Plans.  All unexercised options at June 30, 2018 have an exercise price equal to the fair market value on the date of the grant.

 

Compensation expense of $1,006,900 and $966,600 relating to the vested portion of the fair value of stock options granted was expensed to “Selling, General and Administrative Expenses” in the first six months of 2018 and 2017, respectively.  As of June 30, 2018, the Company had $4.4 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 2.6 years.